Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Identification of Lipophagy Cargo Receptors

EF 2018-19

Résumé
Heart disease is a leading cause of death worldwide. Atherosclerosis underlies many of the complications of cardiovascular disease and arises as lipid-rich plaque builds up within the artery wall. Atherosclerosis occurs over a lifetime and progressively narrows the blood vessels and consequently impedes blood flow in the heart. As the plaque progresses, it becomes unstable and prone to rupture. Plaque rupture can cause a stroke or a heart attack and may result in death. Statins, a class of cholesterol-lowering drugs, are commonly prescribed to patients suffering from atherosclerosis. While statins have the capacity to halt plaque progression, they have little effect on reducing plaque size. As such, the discovery of drugs able to promote lipid removal from cells in the plaque would allow for not only a stop in the progression but reversal of this disease. Cells in our body have a natural ability to degrade cellular components through a recycling system called autophagy. Autophagy allows for the disassembly of large cellular components, such as organelles containing lipids and proteins, into smaller components like fatty acids and amino acids to be reused by the cells. Lipid droplets are small circular organelles used by our cells to store excess lipids and cholesterol which are abundant within the plaque. However, the process of how lipid droplets are recycled through autophagy is poorly understood. Our study will determine which components are involved during autophagy of lipids droplets. Our data will present exciting new opportunities to exploit these components for the development of new therapies that can lead to plaque regression, eliminating the need for invasive surgical procedures to treat heart disease.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
415362
Name
Robichaud Sabrina
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identification of Lipophagy Cargo Receptors
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Atherosclerosis; Autophagy; Lipid Droplet; Macroautophagy; Selective Autophagy
Abstract
Heart disease is a leading cause of death worldwide. Atherosclerosis underlies many of the complications of cardiovascular disease and arises as lipid-rich plaque builds up within the artery wall. Atherosclerosis occurs over a lifetime and progressively narrows the blood vessels and consequently impedes blood flow in the heart. As the plaque progresses, it becomes unstable and prone to rupture. Plaque rupture can cause a stroke or a heart attack and may result in death. Statins, a class of cholesterol-lowering drugs, are commonly prescribed to patients suffering from atherosclerosis. While statins have the capacity to halt plaque progression, they have little effect on reducing plaque size. As such, the discovery of drugs able to promote lipid removal from cells in the plaque would allow for not only a stop in the progression but reversal of this disease. Cells in our body have a natural ability to degrade cellular components through a recycling system called autophagy. Autophagy allows for the disassembly of large cellular components, such as organelles containing lipids and proteins, into smaller components like fatty acids and amino acids to be reused by the cells. Lipid droplets are small circular organelles used by our cells to store excess lipids and cholesterol which are abundant within the plaque. However, the process of how lipid droplets are recycled through autophagy is poorly understood. Our study will determine which components are involved during autophagy of lipids droplets. Our data will present exciting new opportunities to exploit these components for the development of new therapies that can lead to plaque regression, eliminating the need for invasive surgical procedures to treat heart disease.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Robichaud, Sabrina
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~